Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors
about
Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination StrategiesA novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicityPeptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerAdenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.Regulation of the blood-testis barrier by coxsackievirus and adenovirus receptor.Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy.An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors.Virotherapy of neuroendocrine tumors.Gene therapy as a potential tool for treating neuroblastoma-a focused review.iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial.Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses.Inducible epitope imprinting: 'generating' the required binding site in membrane receptors for targeted drug delivery.Seamless assembly of recombinant adenoviral genomes from high-copy plasmids.
P2860
Q26795943-38F45279-403D-4C72-9479-76124F0355D8Q28727030-40562466-D171-4A9B-948D-30C92E98CFCEQ33584756-01E1B011-280C-498B-B5F0-729CAF12E7D5Q34571474-B84C826C-9C48-468C-A719-4D74EEE1F839Q36312788-CA8E0CB1-00BC-40CB-BC75-9D05A027F292Q37101977-8631B73A-B7CF-4A8F-AE37-F2B53BBEF584Q37316842-7DE8EAC6-A2F3-4605-BC5B-A1DFFCDB814DQ37989391-CA5E8977-8964-4925-A757-3BFF92130208Q38808728-22C8FD15-2406-47B0-AE75-725141742926Q38983280-225E76C9-8A7E-4F91-B439-36EB55336CB9Q48319014-72F25354-2E17-4597-9242-6439720A2393Q50423295-B7EA6F9B-4A6A-4E7A-823D-0DE4968ECEE2Q50535283-DB1778C8-090F-4222-BEC2-E339E764DB17Q50656136-94CBE6D8-E2DD-42D4-B7D0-47E8F9EC5C38Q55513326-289040C5-5F3E-44E8-A32F-CE642BAD90AC
P2860
Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@ast
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@en
type
label
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@ast
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@en
prefLabel
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@ast
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@en
P2093
P2860
P356
P1433
P1476
Adenovirus with hexon Tat-prot ...... toma and neuroendocrine tumors
@en
P2093
Berith Nilsson
Justyna Leja
Magnus Essand
Nadim Majdalani
P2860
P304
13114-13123
P356
10.1128/JVI.05759-11
P407
P577
2011-09-28T00:00:00Z